Lobe Sciences (XCNQ:LOBE) ROCE % : 0.00% (As of Feb. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Lobe Sciences's annualized ROCE % for the quarter that ended in Feb. 2024 was 0.00%.

Lobe Sciences ROCE % Historical Data

The historical data trend for Lobe Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences ROCE % Chart

Lobe Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

ROCE %

Get a 7-Day Free Trial

-24.85

-29.46

-54.29

-208.76

-3,132.63

Lobe Sciences Quarterly Data
	Dec18	Mar19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
ROCE %	Get a 7-Day Free Trial															-3,176.38	-	-	-	-

Lobe Sciences ROCE % Calculation

Lobe Sciences's annualized ROCE % for the fiscal year that ended in Aug. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Aug. 2023 )		(A: Aug. 2022 )		(A: Aug. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Aug. 2023 )		(A: Aug. 2022 )		(A: Aug. 2023 )
	=	-4.464	/	( ( (1.748 - 1.302)	+	(2.299 - 2.46) )	/ 2 )
	=	-4.464	/	( (0.446	+	-0.161)	/ 2 )
	=	-4.464	/	0.1425
	=	-3,132.63 %

Lobe Sciences's ROCE % of for the quarter that ended in Feb. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	-2.292	/	( ( (2.19 - 2.871)	+	(2.109 - 3.343) )	/ 2 )
	=	-2.292	/	( ( -0.681	+	-1.234 )	/ 2 )
	=	-2.292	/	-0.9575
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

Lobe Sciences (XCNQ:LOBE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Lobe Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences (XCNQ:LOBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

LOBEF:USA 6YX0:Germany

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines